358 related articles for article (PubMed ID: 22621320)
21. FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness.
Neyroud D; Nosacka RL; Callaway CS; Trevino JG; Hu H; Judge SM; Judge AR
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):421-442. PubMed ID: 33527776
[TBL] [Abstract][Full Text] [Related]
22. Coculture with Colon-26 cancer cells decreases the protein synthesis rate and shifts energy metabolism toward glycolysis dominance in C2C12 myotubes.
Tamura Y; Kouzaki K; Kotani T; Nakazato K
Am J Physiol Cell Physiol; 2024 May; 326(5):C1520-C1542. PubMed ID: 38557354
[TBL] [Abstract][Full Text] [Related]
23. Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways.
Rodriguez J; Vernus B; Chelh I; Cassar-Malek I; Gabillard JC; Hadj Sassi A; Seiliez I; Picard B; Bonnieu A
Cell Mol Life Sci; 2014 Nov; 71(22):4361-71. PubMed ID: 25080109
[TBL] [Abstract][Full Text] [Related]
24. Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation.
Zhang HJ; Wang BH; Wang X; Huang CP; Xu SM; Wang JL; Huang TE; Xiao WL; Tian XL; Lan XQ; Wang QQ; Xiang Y
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):173-188. PubMed ID: 38009816
[TBL] [Abstract][Full Text] [Related]
25. Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs.
Solagna F; Tezze C; Lindenmeyer MT; Lu S; Wu G; Liu S; Zhao Y; Mitchell R; Meyer C; Omairi S; Kilic T; Paolini A; Ritvos O; Pasternack A; Matsakas A; Kylies D; Wiesch JSZ; Turner JE; Wanner N; Nair V; Eichinger F; Menon R; Martin IV; Klinkhammer BM; Hoxha E; Cohen CD; Tharaux PL; Boor P; Ostendorf T; Kretzler M; Sandri M; Kretz O; Puelles VG; Patel K; Huber TB
J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 34060483
[TBL] [Abstract][Full Text] [Related]
26. Licochalcone A and B enhance muscle proliferation and differentiation by regulating Myostatin.
Ahmad K; Lee EJ; Ali S; Han KS; Hur SJ; Lim JH; Choi I
Phytomedicine; 2024 Mar; 125():155350. PubMed ID: 38237512
[TBL] [Abstract][Full Text] [Related]
27. The complex heterogeneity of immune cell signatures across wasting tissues with C26 and 5-fluorouracil-induced cachexia.
VanderVeen BN; Cardaci TD; Bullard BM; Huss AR; McDonald SJ; Muhammed AD; Kubinak JL; Fan D; Murphy EA
Am J Physiol Cell Physiol; 2024 Feb; 326(2):C606-C621. PubMed ID: 38189130
[TBL] [Abstract][Full Text] [Related]
28. Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia.
Pin F; Barreto R; Kitase Y; Mitra S; Erne CE; Novinger LJ; Zimmers TA; Couch ME; Bonewald LF; Bonetto A
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):685-700. PubMed ID: 30009406
[TBL] [Abstract][Full Text] [Related]
29. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia.
Rupert JE; Narasimhan A; Jengelley DHA; Jiang Y; Liu J; Au E; Silverman LM; Sandusky G; Bonetto A; Cao S; Lu X; O'Connell TM; Liu Y; Koniaris LG; Zimmers TA
J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33851955
[TBL] [Abstract][Full Text] [Related]
30. Deliberation on debilitating condition of cancer cachexia: Skeletal muscle wasting.
Dave S; Patel BM
Fundam Clin Pharmacol; 2023 Dec; 37(6):1079-1091. PubMed ID: 37474262
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory Cytokine-Induced Muscle Atrophy and Weakness Can Be Ameliorated by an Inhibition of TGF-β-Activated Kinase-1.
Kanai M; Ganbaatar B; Endo I; Ohnishi Y; Teramachi J; Tenshin H; Higa Y; Hiasa M; Mitsui Y; Hara T; Masuda S; Yamagami H; Yamaguchi Y; Aihara KI; Sebe M; Tsutsumi R; Sakaue H; Matsumoto T; Abe M
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891908
[TBL] [Abstract][Full Text] [Related]
32. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products.
Acharyya S; Ladner KJ; Nelsen LL; Damrauer J; Reiser PJ; Swoap S; Guttridge DC
J Clin Invest; 2004 Aug; 114(3):370-8. PubMed ID: 15286803
[TBL] [Abstract][Full Text] [Related]
33. Exercise training reverses cancer-induced oxidative stress and decrease in muscle COPS2/TRIP15/ALIEN.
Alves CRR; Neves WD; de Almeida NR; Eichelberger EJ; Jannig PR; Voltarelli VA; Tobias GC; Bechara LRG; de Paula Faria D; Alves MJN; Hagen L; Sharma A; Slupphaug G; Moreira JBN; Wisloff U; Hirshman MF; Negrão CE; de Castro G; Chammas R; Swoboda KJ; Ruas JL; Goodyear LJ; Brum PC
Mol Metab; 2020 Sep; 39():101012. PubMed ID: 32408015
[TBL] [Abstract][Full Text] [Related]
34. Myostatin augments muscle-specific ring finger protein-1 expression through an NF-kB independent mechanism in SMAD3 null muscle.
Sriram S; Subramanian S; Juvvuna PK; Ge X; Lokireddy S; McFarlane CD; Wahli W; Kambadur R; Sharma M
Mol Endocrinol; 2014 Mar; 28(3):317-30. PubMed ID: 24438338
[TBL] [Abstract][Full Text] [Related]
35. Myostatin gene invalidation does not prevent skeletal muscle mass loss during experimental sepsis in mice.
Morel J; Pignard AS; Castells J; Allibert V; Hatimi L; Buhot B; Velarde M; Durieux AC; Freyssenet D
J Physiol; 2024 Jun; 602(12):2839-2854. PubMed ID: 38748517
[TBL] [Abstract][Full Text] [Related]
36. Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight.
Lee SJ; Lehar A; Meir JU; Koch C; Morgan A; Warren LE; Rydzik R; Youngstrom DW; Chandok H; George J; Gogain J; Michaud M; Stoklasek TA; Liu Y; Germain-Lee EL
Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23942-23951. PubMed ID: 32900939
[TBL] [Abstract][Full Text] [Related]
37. Protective effects of hachimijiogan (HJG), a Japanese Kampo medicine, on cancer cachectic muscle wasting in mice.
Kametaka S; Isobe M; Komata K; Morinaga M; Nagahata K; Lee-Hotta S; Uchiyama Y; Shibata M; Sugiura H
Biomed Res; 2023; 44(5):199-207. PubMed ID: 37779032
[TBL] [Abstract][Full Text] [Related]
38. Red blood cell extracellular vesicles deliver therapeutic siRNAs to skeletal muscles for treatment of cancer cachexia.
Peng B; Yang Y; Wu Z; Tan R; Pham TT; Yeo EYM; Pirisinu M; Jayasinghe MK; Pham TC; Liang K; Shyh-Chang N; Le MTN
Mol Ther; 2023 May; 31(5):1418-1436. PubMed ID: 37016578
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial fusion and altered beta-oxidation drive muscle wasting in a Drosophila cachexia model.
Dark C; Ali N; Golenkina S; Dhyani V; Blazev R; Parker BL; Murphy KT; Lynch GS; Senapati T; Millard SS; Judge SM; Judge AR; Giri L; Russell SM; Cheng LY
EMBO Rep; 2024 Apr; 25(4):1835-1858. PubMed ID: 38429578
[TBL] [Abstract][Full Text] [Related]
40. Photobiomodulation therapy moderates cancer cachexia-associated muscle wasting through activating PI3K/AKT/FoxO3a pathway.
Li Y; Chen Y; Liao Y; Huang T; Tang Q; He C; Xu L; Chang H; Li H; Liu Q; Lai D; Xia Q; Zou Z
Apoptosis; 2024 Jun; 29(5-6):663-680. PubMed ID: 38598070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
